Privacy should be a human right, and not compromised for ease-of-use ...
Microsoft ships Agent Framework 1.0 but Azure's agent stack still spans too many surfaces while Google and AWS offer cleaner developer paths.
Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.
Recursion has merged Exscientia’s AI-driven chemistry with its own phenomics and a new ClinTech real-world-data capability to streamline discovery and trials, consolidated R&D to five internal ...
For direct API integration and via third-party provider OpenRouter, MiniMax M2.7 maintains a cost-leading price point of 0.30 dollars per 1 million input tokens and 1.20 dollars per 1 million output ...
ARK Invest bought 1.25M shares of Recursion Pharmaceuticals for $4.33M ARK added 37,075 CRISPR Therapeutics shares worth $1.97M PagerDuty was the biggest sell at $3.89M for 566,650 shares ARK also cut ...